Copyright
©The Author(s) 2023.
World J Orthop. Feb 18, 2023; 14(2): 55-63
Published online Feb 18, 2023. doi: 10.5312/wjo.v14.i2.55
Published online Feb 18, 2023. doi: 10.5312/wjo.v14.i2.55
Antifungal drugs | Indication/pathogen | Dosage |
Fluconazole | Candidiasis | 400 mg (6 mg/kg) daily (IV/PO) |
Histoplasmosis | ||
Blastomycosis | ||
Coccidioides | ||
Cryptococcus | ||
Voriconazole | Aspergillus | 4-6 mg/kg BD; 200 mg BD (IV/PO) |
Candidiasis | ||
Coccidioides | ||
Blastomycosis | ||
Cryptococcus | ||
Histoplasmosis | ||
Itraconazole | Aspergillus | 100-400 mg/d (PO) |
Sporothrix | ||
Candidiasis | ||
Coccidioides | ||
Histoplasmosis | ||
Cryptococcus | ||
Blastomycosis | ||
Ketoconazole | Blastomycosis (mild to moderate cases) | 200-400 mg OD (PO) |
Coccidioides | ||
Cryptococcus | ||
Histoplasmosis | ||
Liposomal amphotericin B | Candida species (except C. lusitaniae) | 3-5 mg/kg/d (IV) |
Cryptococcus | ||
Aspergillus | ||
Coccidioides | ||
Histoplasmosis | ||
Sporothrix | ||
Echinocandins: Caspofungin, anidulafungin, micafungin | Candidiasis (fungicidal) | Caspofungin: 70 mg on day 1 followed by 50 mg OD (IV); anidulafungin: 200 mg on day 1 followed by 100 mg OD (IV); micafungin: 100 mg OD (IV) |
Aspergillus (fungistatic) | ||
5-Flucytosine | Cryptococcus | 100 mg/kg/d divided q 6 h (PO) |
Candida |
- Citation: Mishra A, Juneja D. Fungal arthritis: A challenging clinical entity. World J Orthop 2023; 14(2): 55-63
- URL: https://www.wjgnet.com/2218-5836/full/v14/i2/55.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i2.55